Cargando…
Short-Term Outcomes of Treatment of Hip Osteoarthritis With 4 Bone Marrow Concentrate Injections: A Case Series
The use of mesenchymal stem cells from bone marrow concentrate (BMC) has become an increasingly popular option as an alternative to total joint replacement. Although there is evidence to support the use of BMC injections to improve quality of life for patients with knee osteoarthritis (OA), there is...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088468/ https://www.ncbi.nlm.nih.gov/pubmed/30116104 http://dx.doi.org/10.1177/1179547618791574 |
_version_ | 1783346841341919232 |
---|---|
author | Darrow, Marc Shaw, Brent Darrow, Brittany Wisz, Stevie |
author_facet | Darrow, Marc Shaw, Brent Darrow, Brittany Wisz, Stevie |
author_sort | Darrow, Marc |
collection | PubMed |
description | The use of mesenchymal stem cells from bone marrow concentrate (BMC) has become an increasingly popular option as an alternative to total joint replacement. Although there is evidence to support the use of BMC injections to improve quality of life for patients with knee osteoarthritis (OA), there is limited evidence to support its use in patients with hip OA. This case series provides the short-term outcomes of 4 hip OA patients who each underwent 4 BMC injections. On average, the last follow-up was administered 3.5 months after the first injection. The results show that patients experienced decreased resting and active pain compared with baseline and mean 72.4% total overall improvement. Patients also reported less difficulty in performing daily activities following the procedure. These encouraging results warrant further research to better understand the effects of BMC injections on hip OA. |
format | Online Article Text |
id | pubmed-6088468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-60884682018-08-16 Short-Term Outcomes of Treatment of Hip Osteoarthritis With 4 Bone Marrow Concentrate Injections: A Case Series Darrow, Marc Shaw, Brent Darrow, Brittany Wisz, Stevie Clin Med Insights Case Rep Case Report The use of mesenchymal stem cells from bone marrow concentrate (BMC) has become an increasingly popular option as an alternative to total joint replacement. Although there is evidence to support the use of BMC injections to improve quality of life for patients with knee osteoarthritis (OA), there is limited evidence to support its use in patients with hip OA. This case series provides the short-term outcomes of 4 hip OA patients who each underwent 4 BMC injections. On average, the last follow-up was administered 3.5 months after the first injection. The results show that patients experienced decreased resting and active pain compared with baseline and mean 72.4% total overall improvement. Patients also reported less difficulty in performing daily activities following the procedure. These encouraging results warrant further research to better understand the effects of BMC injections on hip OA. SAGE Publications 2018-08-10 /pmc/articles/PMC6088468/ /pubmed/30116104 http://dx.doi.org/10.1177/1179547618791574 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Darrow, Marc Shaw, Brent Darrow, Brittany Wisz, Stevie Short-Term Outcomes of Treatment of Hip Osteoarthritis With 4 Bone Marrow Concentrate Injections: A Case Series |
title | Short-Term Outcomes of Treatment of Hip Osteoarthritis With 4 Bone Marrow Concentrate Injections: A Case Series |
title_full | Short-Term Outcomes of Treatment of Hip Osteoarthritis With 4 Bone Marrow Concentrate Injections: A Case Series |
title_fullStr | Short-Term Outcomes of Treatment of Hip Osteoarthritis With 4 Bone Marrow Concentrate Injections: A Case Series |
title_full_unstemmed | Short-Term Outcomes of Treatment of Hip Osteoarthritis With 4 Bone Marrow Concentrate Injections: A Case Series |
title_short | Short-Term Outcomes of Treatment of Hip Osteoarthritis With 4 Bone Marrow Concentrate Injections: A Case Series |
title_sort | short-term outcomes of treatment of hip osteoarthritis with 4 bone marrow concentrate injections: a case series |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088468/ https://www.ncbi.nlm.nih.gov/pubmed/30116104 http://dx.doi.org/10.1177/1179547618791574 |
work_keys_str_mv | AT darrowmarc shorttermoutcomesoftreatmentofhiposteoarthritiswith4bonemarrowconcentrateinjectionsacaseseries AT shawbrent shorttermoutcomesoftreatmentofhiposteoarthritiswith4bonemarrowconcentrateinjectionsacaseseries AT darrowbrittany shorttermoutcomesoftreatmentofhiposteoarthritiswith4bonemarrowconcentrateinjectionsacaseseries AT wiszstevie shorttermoutcomesoftreatmentofhiposteoarthritiswith4bonemarrowconcentrateinjectionsacaseseries |